Sandro Wealth Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Sandro Wealth Management's NKTR Position: Q3 2026 in Review
Sandro Wealth Management increased its Nektar Therapeutics (NKTR) stake by 31% in Q3 2026, buying an estimated $142K and bringing the position to 8,480 shares worth $513K. The position accounts for 0.33% of the portfolio, ranked #65.
Sandro Wealth Management first reported a position in NKTR in Q2 2026 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Sandro Wealth Management held 8,480 shares of Nektar Therapeutics worth $513K as of Q3 2026.
- Sandro Wealth Management bought 2,025 Nektar Therapeutics shares in Q3 2026, an estimated $142K.
- Nektar Therapeutics made up 0.33% of Sandro Wealth Management's portfolio in Q3 2026, its #65 holding.
- Sandro Wealth Management first reported a position in Nektar Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Sandro Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.